Cempra, Inc. to Present at the Second Annual Generating Evidence for Reimbursement Decisions: Therapeutics Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHAPEL HILL, N.C., Oct. 21, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that Carl Foster, executive vice president, business development, for Cempra, will present at the Second Annual Generating Evidence for Reimbursement Decisions: Therapeutics Conference at 4:15 p.m. EDT, Monday, Oct. 21, at the Hyatt Regency in Bethesda, Md. The conference brings together major stakeholders in the field of evidence-based reimbursement. Mr. Foster will discuss the building of a global value dossier for a novel antibiotic, solithromycin, and differentiating a new therapeutic class.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC